AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

0 Calificaciones
0
Episodio
786 of 1070
Duración
29min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Today's guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today's podcast to talk about challenges in R&D for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

Otros podcasts que te pueden gustar...